Ex Parte Naito - Page 14




               Appeal No. 2005-0126                                                                                              
               Application No. 09/967,791                                                                                        
               the art, or, in some cases the nature of the problem to be solved.”  In re Kotzab, 217                            
               F.3d 1365, 1369, 55 USPQ2d 1313,1317 (Fed. Cir. 2000); Pro-Mold &Tool Co. v. Great                                
               Lakes Plastics, Inc., 75 F.3d at 1573, 37 USPQ2d at 1630.  In this case, I find that the                          
               suggestion to arrive at the claimed invention arises primarily from the latter two, i.e.,                         
               from knowledge of those having ordinary skill in the art and the nature of the problem to                         
               be solved.                                                                                                        
                      Here, I find that all parties, the examiner, the appellant and the majority, are in                        
               agreement that both Naito and Keep evince that the use of hypertonic sugar                                        
               compositions to increase the permeability of the blood-brain barrier for passage by other                         
               compounds was known in the art at the time the application was filed.  To that end, the                           
               examiner points out that Naito discloses that a hypertonic sugar solution provides “a                             
               vehicle and a method for transporting substances across the blood brain barrier.”                                 
               Answer, p. 5, pointing to Naito, col. 2, lines 2-4.  The examiner further points out similar                      
               teachings in Keep.  Answer, p. 6 relying on Keep col. 5, lines 35-42 and                                          
               col. 6, lines 29-33.  The applied prior art also discloses that the hypertonic sugar                              
               composition can be administered “in combination, simultaneously or in sequence” with                              
               the compound of interest (i.e., the compound/medication for which it is desired to treat                          
               the nervous system).  Keep, col. 6, lines 29-33; Naito, col. 3, lines 39-50.  Thus, the only                      
               difference between the claimed method and the methods taught by Naito and Keep is                                 
               the route of administration of the hypertonic sugar composition.  In this regard,                                 



                                                               14                                                                





Page:  Previous  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  Next 

Last modified: November 3, 2007